pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·Jul 28·1 min read
save

WHO publishes first interim list of 12 medical device regulators eligible for WHO-listed authority status

Jul 28, 2026·read at raps ↗RegulatoryNeutral

The World Health Organization has released its first interim list of medical device regulators that can attain WHO-listed authority status.

The list names 12 regulators from different regions that passed an evaluation and will hold transitional listed status while they work toward full WHO-listed authority designation.

The initiative aims to harmonize device oversight worldwide and could influence how manufacturers navigate regulatory pathways for market entry.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “WHO announces first global list of medical device regulators eligible for listed authority standing”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoIndustry asks FDA to expand prior knowledge guidanceraps
  • 1d agoRecon: CBER official overruled Replimune melanoma drug rejection; AbbVie claims Phase 3 win for multiple myeloma drugraps
  • 1d agoEuro Roundup: UK government moves to modernize legislative framework for medicines and devicesraps
  • 2d agoEMA launches data sharing pilot to gain confidence in NAMs, reduce animal testingraps
  • 3d agoRecon: Trump announces new pricing deals with midsize biotechs; Novartis pauses CAR-T trials after patient deathsraps